The trader works at the Goldman Sachs booth on the floor of the New York Stock Exchange.
Brendan McDermid Reuters
Analysts from Goldman Sachs have named a dozen stocks with a “significant upside” as coronavirus vaccines split and blockages begin to grow.
The bank has launched a scale that follows the pace of reopening, looking at data such as highway traffic, retail, school opening and job advertising, and has created a list of about 70 stocks that should benefit. In a note released Monday, analysts then selected 12 shares “strongly adjusted” for the recovery, which all banks buy with a rating.
Below is a complete list of stocks, and Goldman analysts say most of them have a growth potential of 20% or more, with one going to pick up as much as 60%.